Research points to an immunotherapy to overcome resistant leukemia
by University of ZurichTP53 deficiency in AML leads to resistance against CAR T-cell-mediated killing that can be overcome by targeting the mevalonate and Wnt pathways. Credit:EMBO Molecula
Updated on: March 30,2024
0

Research points to an immunotherapy to overcome resistant leukemia
by University of ZurichTP53 deficiency in AML leads to resistance against CAR T-cell-mediated killing that can be overcome by targeting the mevalonate and Wnt pathways. Credit:EMBO Molecula
Updated on:March 30,2024
0
